chartexchange

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc. | Nov 18, 2026 4:05 PM EST

FOSTER CITY, Calif., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused commercial stage biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today reported that, effective November 17, 2026, it granted stock options to purchase an aggregate of 150,000 shares of common stock to three newly hired employees as an inducement material to such employees’ acceptance of employment with Geron.

Read original article